This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Contract Research Organizations (CROs) Market To 2018 - Public-Private Partnerships To Strengthen Research Capacities And Advance Clinical Development Programs

Figure 25: Contract Research Organization Market to 2018, Blanchard & Asociados, Company Profile, 2011 53

Figure 26: Contract Research Organization Market to 2018, EGCP, Company Profile, 2011 54

Figure 27: Contract Research Organization Market to 2018, Klixar, Company Profile, 2011 55

Figure 28: Contract Research Organization Market to 2018, LatinClin, Company Profile, 2011 56

Figure 29: Contract Research Organization Market to 2018, Mmatiss, Company Profile, 2011 57

Figure 30: Contract Research Organization Market to 2018, Estudios Clínicos Latinoamérica, Company Profile, 2011 58

Figure 31: Contract Research Organization Market to 2018, Clinical Trial Market, India, ($m), 2008–2018 59

Figure 32: Contract Research Organization Market to 2018, Reliance Life Sciences, India, 2011 60

Figure 33: Contract Research Organization Market to 2018, Asian Clinical Trials, India, 2011 61

Figure 34: Contract Research Organization Market to 2018, DiagnoSearch Life Sciences, India, 2011 62

Figure 35: Contract Research Organization Market to 2018, ClinInvent, India, 2011 63

Figure 36: Contract Research Organization Market to 2018, Synchron Research Services, India, 2011 64

Figure 37: Contract Research Organization Market to 2018, Lambda Therapeutics, India, 2011 65

Figure 38: Contract Research Organization Market to 2018, GVK Biosciences, India, 2011 66

Figure 39: Contract Research Organization Market to 2018, Veeda Clinical Research, India, 2011 67

Figure 40: Contract Research Organization Market to 2018, Ecron Acunova, India, 2011 68

Figure 41: Contract Research Organization Market to 2018, Siro Clinpharm, India, 2011 69

Figure 42: Contract Research Organization Market to 2018, Clinical Trial Market, China, ($m), 2008–2018 70

Figure 43: Contract Research Organization Market to 2018, Boji Medicine Services Co. Ltd, Company Profile, 2011 71

Figure 44: Contract Research Organization Market to 2018, Giant Med-Pharma Services Inc, Company Profile, 2011 72

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,011.94 -28.43 -0.16%
S&P 500 2,109.60 -2.13 -0.10%
NASDAQ 5,076.5240 -6.4050 -0.13%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs